FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2414611318> ?p ?o ?g. }

• W2414611318 endingPage "112" @default.
• W2414611318 startingPage "106" @default.
• W2414611318 abstract "Selective phosphodiesterases (PDE) inhibitors are the new group of antiasthmatic drugs, which integrateantiinflammatory activity with bronchoconstriction counteraction. Selective inhibitors of phosphodiesterase type 4 are used as alternative or assist drugs in treatment of respiratory system diseases. So far glucocorticosteroidsremain the most efficient and widely used medicine in the treatment of asthma. However application of glucocorticosteroid is greatly limited because of numerous side effects, what induce to permanent search for new antiasthmatic drugs. Examination new substances are executed on animal models. Guinea pig model is widely used to research course of asthmatic reaction. This model is especially convenient on the ground of that: lung is major shock organ, airway respond to histamine, animals demonstrated early asthmatic reaction (EAR) and late asthmatic reaction (LAR), eosinophils flow in bronchoalveolar space during LAR. Inovalbumin(OA)sensitized guine a pigs hypersensitivity reaction breaks out as a result of OA provocation.Aims of our experiments, execute on guinea pig model were to determine the influence of rolipram (PDE 4 inhibitor)on modulation experimental asthmatic reaction and comparison activity of rolipram versus dexamethasone in attribution to chosen parameters of allergic reaction such as: lung resistance, influxofproteinandinflammatorycells in airways, and mastocytes degranulation. Experiments were made on guinea pigs sensitized and provoked with ovalbumin The obtain data indicate that rolipram was effective in reduction the rise of lung resistance during EAR, restricted influx of eosinophils to bronchoalveolar space between 1,5 and 24 hours after provocation, andreduced increase of histamine concentration in bronchoalveolar lavage fluid(BALf).Rolipramhadnoinfluenceon number of neutrophils present in BALf. Dexamethasone in double dose of 1,2mg/kg effectively bordered the growth of lung resistance during EAR, and broke influx of eosinophils and neutrophils to bronchoalveolar space." @default.
• W2414611318 created "2016-06-24" @default.
• W2414611318 creator A5019709225 @default.
• W2414611318 creator A5022774958 @default.
• W2414611318 creator A5048094805 @default.
• W2414611318 creator A5071086804 @default.
• W2414611318 date "2006-01-01" @default.
• W2414611318 modified "2023-09-25" @default.
• W2414611318 title "[Effect of phosphodiestrase 4 inhibitor (rolipram) on experimental allergic asthma-guinea pig model]." @default.
• W2414611318 cites W1538224608 @default.
• W2414611318 cites W1542652830 @default.
• W2414611318 cites W1571786613 @default.
• W2414611318 cites W1846790322 @default.
• W2414611318 cites W1895515385 @default.
• W2414611318 cites W1909984090 @default.
• W2414611318 cites W1950911341 @default.
• W2414611318 cites W1952894661 @default.
• W2414611318 cites W1963641377 @default.
• W2414611318 cites W1977177612 @default.
• W2414611318 cites W1984534195 @default.
• W2414611318 cites W1990167427 @default.
• W2414611318 cites W1996515306 @default.
• W2414611318 cites W2028608038 @default.
• W2414611318 cites W2029944874 @default.
• W2414611318 cites W2064916875 @default.
• W2414611318 cites W2126384633 @default.
• W2414611318 cites W2134238592 @default.
• W2414611318 cites W2141710896 @default.
• W2414611318 cites W2142844505 @default.
• W2414611318 cites W2407869812 @default.
• W2414611318 cites W2418638525 @default.
• W2414611318 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17175988" @default.
• W2414611318 hasPublicationYear "2006" @default.
• W2414611318 type Work @default.
• W2414611318 sameAs 2414611318 @default.
• W2414611318 citedByCount "0" @default.
• W2414611318 crossrefType "journal-article" @default.
• W2414611318 hasAuthorship W2414611318A5019709225 @default.
• W2414611318 hasAuthorship W2414611318A5022774958 @default.
• W2414611318 hasAuthorship W2414611318A5048094805 @default.
• W2414611318 hasAuthorship W2414611318A5071086804 @default.
• W2414611318 hasConcept C110586980 @default.
• W2414611318 hasConcept C1122143 @default.
• W2414611318 hasConcept C126322002 @default.
• W2414611318 hasConcept C142724271 @default.
• W2414611318 hasConcept C147483822 @default.
• W2414611318 hasConcept C170493617 @default.
• W2414611318 hasConcept C181199279 @default.
• W2414611318 hasConcept C185592680 @default.
• W2414611318 hasConcept C203014093 @default.
• W2414611318 hasConcept C204787440 @default.
• W2414611318 hasConcept C2776042228 @default.
• W2414611318 hasConcept C2776946954 @default.
• W2414611318 hasConcept C2776958096 @default.
• W2414611318 hasConcept C2777714996 @default.
• W2414611318 hasConcept C2777961210 @default.
• W2414611318 hasConcept C2778815084 @default.
• W2414611318 hasConcept C2780401358 @default.
• W2414611318 hasConcept C2780769369 @default.
• W2414611318 hasConcept C33362165 @default.
• W2414611318 hasConcept C49802076 @default.
• W2414611318 hasConcept C55493867 @default.
• W2414611318 hasConcept C62826618 @default.
• W2414611318 hasConcept C71924100 @default.
• W2414611318 hasConcept C98274493 @default.
• W2414611318 hasConceptScore W2414611318C110586980 @default.
• W2414611318 hasConceptScore W2414611318C1122143 @default.
• W2414611318 hasConceptScore W2414611318C126322002 @default.
• W2414611318 hasConceptScore W2414611318C142724271 @default.
• W2414611318 hasConceptScore W2414611318C147483822 @default.
• W2414611318 hasConceptScore W2414611318C170493617 @default.
• W2414611318 hasConceptScore W2414611318C181199279 @default.
• W2414611318 hasConceptScore W2414611318C185592680 @default.
• W2414611318 hasConceptScore W2414611318C203014093 @default.
• W2414611318 hasConceptScore W2414611318C204787440 @default.
• W2414611318 hasConceptScore W2414611318C2776042228 @default.
• W2414611318 hasConceptScore W2414611318C2776946954 @default.
• W2414611318 hasConceptScore W2414611318C2776958096 @default.
• W2414611318 hasConceptScore W2414611318C2777714996 @default.
• W2414611318 hasConceptScore W2414611318C2777961210 @default.
• W2414611318 hasConceptScore W2414611318C2778815084 @default.
• W2414611318 hasConceptScore W2414611318C2780401358 @default.
• W2414611318 hasConceptScore W2414611318C2780769369 @default.
• W2414611318 hasConceptScore W2414611318C33362165 @default.
• W2414611318 hasConceptScore W2414611318C49802076 @default.
• W2414611318 hasConceptScore W2414611318C55493867 @default.
• W2414611318 hasConceptScore W2414611318C62826618 @default.
• W2414611318 hasConceptScore W2414611318C71924100 @default.
• W2414611318 hasConceptScore W2414611318C98274493 @default.
• W2414611318 hasIssue "1" @default.
• W2414611318 hasLocation W24146113181 @default.
• W2414611318 hasLocation W24146113182 @default.
• W2414611318 hasOpenAccess W2414611318 @default.
• W2414611318 hasPrimaryLocation W24146113181 @default.
• W2414611318 hasRelatedWork W1264715030 @default.
• W2414611318 hasRelatedWork W1965819980 @default.
• W2414611318 hasRelatedWork W1975453068 @default.
• W2414611318 hasRelatedWork W2000769210 @default.

• next